Page 2 - Bellevue Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bellevue group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bellevue Group Today - Breaking & Trending Today

Pfizer Inc. (NYSE:PFE) Shares Purchased by Mmbg Investment Advisors CO.

Mmbg Investment Advisors CO. grew its position in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 157,855 shares of the biopharmaceutical company’s stock after purchasing an additional 18,730 shares during the period. Mmbg […] ....

United States , Pfizer Inc , Cantor Fitzgerald , Morgan Stanley , Exchange Commission , American Trust Investment Advisors , Bellevue Group , Humankind Investments , Mmbg Investment Advisors , Pfizer Company Profile , Cheviot Value Management , Free Report , Investment Advisors , Value Management , Trust Investment Advisors , Trading Down , Get Free Report , Pfizer Daily ,

HUTCHMED (NASDAQ:HCM) Raised to "Buy" at StockNews.com

HUTCHMED (NASDAQ:HCM – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. HUTCHMED Price Performance Shares of HCM traded up $0.32 on Monday, reaching $18.08. 219,565 shares of the company’s stock were exchanged, compared to its average volume of […] ....

Hong Kong , Mg Plc , Baillie Gifford Co , Bellevue Group , Acadian Asset Management , Hsbc Holdings , Get Free Report , Asset Management , Baillie Gifford ,

Avidity Partners Management LP Lowers Holdings in Becton, Dickinson and Company (NYSE:BDX)

Avidity Partners Management LP reduced its stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 42.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 165,706 shares of the medical instruments supplier’s stock after selling […] ....

Thomasj Spoerel , Becton Dickinson , Vontobel Asset Management Inc , Exchange Commission , Veritas Asset Management , Goldman Sachs Group , Bellevue Group , Company Daily , Company Dividend Announcement , Bd Life Sciences , Securities Exchange Commission , Company Trading Down , Avidity Partners Management , Free Report , Partners Management , Asset Management , Get Free Report , Company Dividend , Visit Holdingschannel ,

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Brucei Sachs , Reshma Kewalramani , Piper Sandler , News Ratings For Vertex Pharmaceuticals Daily , Insider Transactions At Vertex Pharmaceuticals , Canaccord Genuity Group , Securities Exchange Commission , Vertex Pharmaceuticals Profile , Wolfe Research , Bellevue Group , Telos Capital Management Inc , Quarter For Vertex Pharmaceuticals , Investment Management , Cantor Fitzgerald , Exchange Commission , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals , Sherbrooke Park Advisers , Vertex Pharmaceuticals Stock , Morgan Stanley , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Director Bruce ,

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is Bellevue Group AG's 3rd Largest Position

Bellevue Group AG trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 5.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,430,500 shares of the company’s stock after selling 153,050 shares during the period. Neurocrine […] ....

United States , Eric Benevich , Neurocrine Biosciences , Stephena Sherwin , Bellevue Group , Wealth Alliance , Hightower Advisors , Janney Montgomery Scott , Charles Schwab Investment Management Inc , Neurocrine Biosciences Company Profile , Pathstone Family Office , Neurocrine Biosciences Inc , Exchange Commission , Wells Fargo Company , Free Report , Montgomery Scott , Schwab Investment Management , Family Office , Tower Advisors , Director Stephen , Biosciences Trading Down , Get Free Report , Visit Holdingschannel , Neurocrine Biosciences Daily ,